NFKB1 and cancer: However, the knockdown of p65 abolished the increase of PPARδ proteins-induced by HBXIP (Figure 3E, 3F and Supplementary Figure 2B), indicating that HBXIP boosts the expression of PPARδ in a NF-κB-dependent manner in cancer cells.